Cryoport CFO Sells $2.76 Million in Company Stock
CYRX has more than doubled off its 52-week low of $6.16.
Summary
Cryoport's Chief Financial Officer, Robert Stefanovich, sold 169,427 shares of common stock for approximately $2.76 million, following a recent Form 144 filing indicating intent to sell.
Key Events · Ownership and Investor Activity · CYRX
-
CFO Sells Shares
Robert Stefanovich, Chief Financial Officer, disposed of 169,427 shares of Cryoport common stock.
-
Significant Transaction Value
The open-market sale totaled approximately $2.76 million at an average price of $16.27 per share.
-
Follows Prior Intent
This Form 4 confirms the execution of a sale previously indicated by a Form 144 filed on June 3, 2026, for a similar amount.
-
Executive Distribution
This transaction contributes to a net insider distribution trend for Cryoport over the past 90 days, with total insider sales of $706,662.
Analysis · CYRX · Life Sciences
This significant open-market sale by a key executive like the CFO typically signals a lack of confidence or a need for personal liquidity. The transaction value represents a notable portion of the company's market capitalization, and it follows a Form 144 filed just days prior, confirming the execution of the previously signaled intent to sell. This adds to a pattern of net insider distribution over the last 90 days.
At the time of this filing, CYRX was trading at $15.48 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $780.2M. The 52-week trading range was $6.16 to $16.73. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.